Compounds target cancer stem cells
New compounds that target leukemia stem cells are moving into the clinic this summer. But researchers have yet to pin down exactly how some of these compounds do their job. Today at the International Society for Stem Cell Research's (ISSCR) annual meeting, linkurl:Craig Jordan;http://www.urmc.rochester.edu/GEBS/faculty/Craig_Jordan.htm from the University of Rochester presented his group's recent work on a compound TDZD-8, which was originally developed to inhibit GSK-3, and potentially treat A
Written byAndrea Gawrylewski
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Meet the Author
This person does not yet have a bio.View Full Profile
Share
